Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

<p>Abstract</p> <p>Background</p> <p>Cancer and its therapies increase the risk of venous thromboembolism. Compared to patients without cancer, patients with cancer anticoagulated for venous thromboembolism are more likely to develop recurrent thrombotic events and majo...

Full description

Bibliographic Details
Main Authors: Sperati Francesca, Terrenato Irene, Rohilla Sandeep, Barba Maddalena, Akl Elie A, Muti Paola, Schünemann Holger J
Format: Article
Language:English
Published: BMC 2008-07-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/27/1/21

Internet

http://www.jeccr.com/content/27/1/21

Similar Items